Recursion, the AI drug development company, cuts more jobs after finalizing Exscientia merger Recursion is working on 10 potential drugs, and has enough cash to fuel itself through 2027

https://www.statnews.com/2024/11/26/recursion-biotech-job-cuts-layoffs-exscientia-merger-ai-drug-development/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz-_aQLkgv5JoMCon3ZV5c-kOH06y4Cq_HzbTg3qDleJm74Qy7MxUn2lbXvPJRdLs7vFpsrEDPTSjGb0M95rc8TE0HDau6g&_hsmi=336007103&utm_content=336007103&utm_source=hs_email